Optimization of stroke prophylaxis strategies in nonvalvular AF - Drugs, devices or both?

Amit Noheria, Faisal F. Syed, Christopher V. De Simone, Samuel J Asirvatham

Research output: Contribution to journalArticle

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia with the prevalence increasing over time. AF probably afflicts ≥2% of worldwide adult population and increases with age.<sup>1-3</sup> In the Framingham Heart Study, the lifetime risk of having at least one episode of AF for 40-year-old men and women was 26% and 23% respectively.<sup>4</sup>.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalJournal of Atrial Fibrillation
Volume8
Issue number2
StatePublished - Aug 1 2015

Keywords

  • Anticoagulation
  • Defibrillation
  • Device
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Optimization of stroke prophylaxis strategies in nonvalvular AF - Drugs, devices or both?'. Together they form a unique fingerprint.

  • Cite this